Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term versus long-term ceftibuten for acute pyelonephritis in children
2008-003209-16Phase 3Terminated
- Sponsor
- IRCCS Burlo Garofolo
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of ceftibuten in acute pyelonephritis (2 arms), sponsored by IRCCS Burlo Garofolo. Primary endpoint: Renal scarring at 6–12 months. Started Jul 2008; status: terminated.
02
Drugs
ceftibuten
03
Conditions
acute pyelonephritis
Beyond the preview
Go deeper on 2008-003209-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003209-16.